SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth SuppressionChuandong Geng, Timothy C. Thompson, Man-Chao Zhang et al.|Clinical Cancer Research|2023Cited by 24
Supplementary Methods S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth SuppressionChuandong Geng, Timothy C. Thompson, Man-Chao Zhang et al.|Unknown|2023Cited by 0
Supplementary Figure S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth SuppressionChuandong Geng, Timothy C. Thompson, Man-Chao Zhang et al.|Unknown|2023Cited by 0
Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth SuppressionChuandong Geng, Timothy C. Thompson, Man-Chao Zhang et al.|Unknown|2023Cited by 0
Supplementary Figure S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth SuppressionChuandong Geng, Timothy C. Thompson, Man-Chao Zhang et al.|Unknown|2023Cited by 0